These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23368651)
1. Influence of genetics on tumoral pathologies: the example of the adenocarcinoma arising in Barrett's esophagus. Villanacci V; Bassotti G; Salemme M; Rossi E Rev Esp Enferm Dig; 2012 Dec; 104(11):592-602. PubMed ID: 23368651 [TBL] [Abstract][Full Text] [Related]
2. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
3. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence]. Mokrowiecka A; Wierzchniewska-Ćawska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma. Beilstein M; Silberg D Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613 [TBL] [Abstract][Full Text] [Related]
6. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156 [TBL] [Abstract][Full Text] [Related]
7. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
8. Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. Levine DS; Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS Gastroenterology; 1989 Feb; 96(2 Pt 1):355-67. PubMed ID: 2910757 [TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754 [TBL] [Abstract][Full Text] [Related]
10. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia. Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128 [TBL] [Abstract][Full Text] [Related]
11. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]
12. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035 [TBL] [Abstract][Full Text] [Related]
14. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z; Mickevicius A; Kiudelis M Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039 [TBL] [Abstract][Full Text] [Related]
15. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma. Kaz AM; Grady WM; Stachler MD; Bass AJ Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206 [TBL] [Abstract][Full Text] [Related]
16. Surgical management of Barrett's esophagus. Clark GW; DeMeester TR Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371 [TBL] [Abstract][Full Text] [Related]
17. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Dolan K; Garde J; Walker SJ; Sutton R; Gosney J; Field JK Hum Pathol; 1999 Dec; 30(12):1508-14. PubMed ID: 10667431 [TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Sarr MG; Hamilton SR; Marrone GC; Cameron JL Am J Surg; 1985 Jan; 149(1):187-93. PubMed ID: 3966636 [TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus. Dolan K; Morris AI; Gosney JR; Field JK; Sutton R J Gastroenterol Hepatol; 2003 Jun; 18(6):683-9. PubMed ID: 12753151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]